AAAAAA

   
Results: 1-7 |
Results: 7
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solidtumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction
Authors: Kohn, EC Reed, E Sarosy, GA Minasian, L Bauer, KS Bostick-Bruton, F Kulpa, V Fuse, E Tompkins, A Noone, M Goldspiel, B Pluda, J Figg, WD Liotta, LA
Citation: Ec. Kohn et al., A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solidtumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction, CLIN CANC R, 7(6), 2001, pp. 1600-1609
Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833
Authors: Chico, I Kang, MH Bergan, R Abraham, J Bakke, S Meadows, B Rutt, A Robey, R Choyke, P Merino, M Goldspiel, B Smith, T Steinberg, S Figg, WD Fojo, T Bates, S
Citation: I. Chico et al., Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833, J CL ONCOL, 19(3), 2001, pp. 832-842
A phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar)
Authors: Bates, S Kang, M Meadows, B Bakke, S Choyke, P Merino, M Goldspiel, B Chico, I Smith, T Chen, C Robey, R Bergan, R Figg, WD Fojo, T
Citation: S. Bates et al., A phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar), CANCER, 92(6), 2001, pp. 1577-1590
Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high riskfor developing invasive breast cancer
Authors: Conley, B O'Shaughnessy, J Prindiville, S Lawrence, J Chow, C Jones, E Merino, MJ Kaiser-Kupfer, MI Caruso, RC Podger, M Goldspiel, B Venzon, D Danforth, D Wu, SL Noone, M Goldstein, J Cowan, KH Zujewski, J
Citation: B. Conley et al., Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high riskfor developing invasive breast cancer, J CL ONCOL, 18(2), 2000, pp. 275-283
A phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumors
Authors: Grem, JL Sorensen, JM Cullen, E Takimoto, CH Steinberg, SM Chen, AP Hamilton, JM Arbuck, SG McAtee, N Lawrence, D Goldspiel, B Johnston, PG Allegra, CJ
Citation: Jl. Grem et al., A phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumors, CLIN CANC R, 5(9), 1999, pp. 2381-2391
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing themultidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients
Authors: Cowan, KH Moscow, JA Huang, H Zujewski, JA O'Shaughnessy, J Sorrentino, B Hines, K Carter, C Schneider, E Cusack, G Noone, M Dunbar, C Steinberg, S Wilson, W Goldspiel, B Read, EJ Leitman, SF McDonagh, K Chow, C Abati, A Chiang, Y Chang, YN Gottesman, MM Pastan, I Nienhuis, A
Citation: Kh. Cowan et al., Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing themultidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients, CLIN CANC R, 5(7), 1999, pp. 1619-1628
Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy
Authors: Moscow, JA Huang, H Carter, C Hines, K Zujewski, J Cusack, G Chow, C Venzon, D Sorrentino, B Chiang, YW Goldspiel, B Leitman, S Read, EJ Abati, A Gottesman, MM Pastan, I Sellers, S Dunbar, C Cowan, KH
Citation: Ja. Moscow et al., Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy, BLOOD, 94(1), 1999, pp. 52-61
Risultati: 1-7 |